US FDA to phase out animal testing in drug development
Go back to US FDA to phase out animal testing in drug development| CHARLES RIVER LABORATORIE (NYSE: CRL) | Delayed: 290.27 +11.08 (3.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $279.19 | 52 Week High | $89.18 | |||
| Open | $284.22 | 52 Week Low | $65.70 | |||
| Day High | $294.56 | P/E | 135.01 | |||
| Day Low | $280.68 | EPS | $2.15 | |||
| Volume | 709,486 | |||||
